Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CHLORAMBUCIL Cause Therapy partial responder? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Therapy partial responder have been filed in association with CHLORAMBUCIL (LEUKERAN). This represents 0.3% of all adverse event reports for CHLORAMBUCIL.

7
Reports of Therapy partial responder with CHLORAMBUCIL
0.3%
of all CHLORAMBUCIL reports
2
Deaths
2
Hospitalizations

How Dangerous Is Therapy partial responder From CHLORAMBUCIL?

Of the 7 reports, 2 (28.6%) resulted in death, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CHLORAMBUCIL. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CHLORAMBUCIL Cause?

Off label use (176) Neutropenia (173) Pneumonia (158) Pyrexia (132) Acute myeloid leukaemia (107) Disease progression (104) Drug ineffective (103) Febrile neutropenia (94) Thrombocytopenia (93) Myositis (89)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which CHLORAMBUCIL Alternatives Have Lower Therapy partial responder Risk?

CHLORAMBUCIL vs CHLORAMPHENICOL CHLORAMBUCIL vs CHLORDIAZEPOXIDE CHLORAMBUCIL vs CHLORDIAZEPOXIDE\CLIDINIUM CHLORAMBUCIL vs CHLORHEXIDINE CHLORAMBUCIL vs CHLORHEXIDINE\CHLORHEXIDINE

Related Pages

CHLORAMBUCIL Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder CHLORAMBUCIL Demographics